HCPLive Network

Fred Poordad, MD, on Ethnic Differences in Telaprevir Treatment Effect

In this video Fred Poordad, MD, Chief of Hepatology and Liver Transplantation at the Comprehensive Transplant Center at Cedars-Sinai Medical Center evaluates the effect of race on the response to treatment and viral resistance profiles with telaprevir combination therapy.

 
Related Videos
Paul Offit, MD, from The Children's Hospital of Philadelphia, talked about vaccine safety and the ongoing public health effects of misinformation about this topic.
Inflammatory bowel disease patients are already benefiting from technology advancements in healthcare, but there are barriers to providing care through telemedicine, Raymond Cross, MD.
Since pancreatic cancer is so rare, screening among the general population is not worthwhile, according to Randall Brand, MD. Instead, physicians should only screen those individuals considered "high risk."